amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
| UniProt | Protein Name |
|---|---|
| A0A0S2A4E4 |
|
| P35573 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| glycogen biosynthetic process | ||
| glycogen catabolic process | ||
| glycogen catabolic process | ||
| response to nutrient | ||
| response to glucocorticoid |
| GO Term | Evidence Code | PMID |
|---|---|---|
| glycogen debranching enzyme activity | ||
| 4-alpha-glucanotransferase activity | ||
| 4-alpha-glucanotransferase activity | ||
| amylo-alpha-1,6-glucosidase activity | ||
| amylo-alpha-1,6-glucosidase activity |
| Gene Ontology |
|---|
| 4-alpha-glucanotransferase activity |
| amylo-alpha-1,6-glucosidase activity |
| glycogen biosynthetic process |
| glycogen catabolic process |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:2748 | glycogen storage disease III |
| HPO ID | HPO Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000219 | Thin upper lip vermilion |
| HP:0000233 | Thin vermilion border |
| HP:0000272 | Malar flattening |
| HP:0000293 | Full cheeks |
| HP:0000455 | Broad nasal tip |
| HP:0000490 | Deeply set eye |
| HP:0001256 | Intellectual disability, mild |
| HP:0001324 | Muscle weakness |
| HP:0001395 | Hepatic fibrosis |
| Disease ID | Disease Name |
|---|---|
| OMIM:232400 |
|
| ORPHA:366 |
|
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 178 | Xenbase:XB-GENE-1001429 | ||
| 77559 | MOUSE36551 | ||
| 362029 | RATNO25161 | ||
| 469392 | PANTR21651 | ||
| 479931 | CANLF16878 | ||
| 517397 | BOVIN26443 | ||
| 567798 | DANRE29999 | ||
| 710910 | MACMU24389 | ||
| 856314 | Xenbase:XB-GENE-1001429 | ||
| 100009066 | RABIT03663 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025